TAP
54
-3
XEL
51
3
STT
59
11
XRX
59
11
PGR
49
4
HSIC
44
2
HUM
29
4
O
20
-6
PFG
30
3
CHD
32
-2
LLY
45
8
EQT
50
3
BBY
46
-2
PLD
37
2
NI
67
2
CB
48
2
INTC
37
2
ISRG
66
2
K
48
3
ESS
47
3
TAP
54
-3
XEL
51
3
STT
59
11
XRX
59
11
PGR
49
4
HSIC
44
2
HUM
29
4
O
20
-6
PFG
30
3
CHD
32
-2
LLY
45
8
EQT
50
3
BBY
46
-2
PLD
37
2
NI
67
2
CB
48
2
INTC
37
2
ISRG
66
2
K
48
3
ESS
47
3
Financhill
Back

Jones Lang LaSalle Vs. Viking Therapeutics Industry Stock Comparison

Buy
60

JLL
Jones Lang LaSalle

Last Price:
$255.15
Seasonality Move:
10.07%
Sell
24

VKTX
Viking Therapeutics

Last Price:
$42.32
Seasonality Move:
21.99%
Buy
60
Jones Lang LaSalle (JLL) is a Buy

Is Jones Lang LaSalle a Buy, Sell or Hold?

  • The current Jones Lang LaSalle [JLL] share price is $254.09. The Score for JLL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • JLL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $42.32. The Score for VKTX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JLL Stock Price Chart

What is Jones Lang LaSalle's stock price today?

  • The Jones Lang LaSalle share price today is $254.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $42.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

JLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.83 Sell
Relative Strength Index (14 RSI): 39.58 Sell
Chaikin Money Flow: 179269 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (258.47 - 279.55) Sell
Bollinger Bands (100): (248.44 - 272.88) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.12 Sell
Relative Strength Index (14 RSI): 34.11 Sell
Chaikin Money Flow: 1790477 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.93 - 52.95) Sell
Bollinger Bands (100): (51.14 - 67.26) Sell

JLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 261.67 Sell
20-day SMA: 271.3 Sell
50-day SMA: 268.48 Sell
200-day SMA: 230.48 Buy
8-day EMA: 259.58 Sell
20-day EMA: 265.61 Sell
50-day EMA: 265.74 Sell
200-day EMA: 236.35 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.15 Sell
20-day SMA: 48.36 Sell
50-day SMA: 57.36 Sell
200-day SMA: 61.6 Sell
8-day EMA: 43.94 Sell
20-day EMA: 47.83 Sell
50-day EMA: 53.74 Sell
200-day EMA: 54.24 Sell

Jones Lang LaSalle Earnings Growth & JLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.32 per share, and an increase next year of $2.96 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.

Jones Lang LaSalle Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):